Abstract
In this manuscript we will cover four specific points regarding “transfer factor”: First, its efficacy. Second, its specificity. Third, the potency of various preparations; how potency assays were devised and their use. Fourth and last, a model we developed to study human tumors in tolerized animals; the model is illustrated by experiments using antigen specific transfer factor induced in rabbits, hamsters, and other animals by injecting antigen from osteosarcoma cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
H.S. Lawrence, Transfer in human of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leukocytes, J. Clin. Invest. 34: 219 (1955).
A.S. Levin, L.E. Spitler, D.P. Stites, and H.H. Fudenberg, Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor, Proc. Nat. Acad. Sci. 67: 821 (1970).
J. Wybran, A.S. Levin, L.E. Spitler, and H.H. Fudenberg, Rosette-forming cells, Immunologic deficiency diseases and transfer factor, N. Engl. J. Med. 288: 710 (1973).
H.H. Fudenberg, A.S. Levin, L.E. Spitler, J. Wybran, and V. Byers, The therapeutic uses of transfer factor, Hosp. Pract. 9: 95 (1974).
H.H. Fudenberg, J.M. Goust, M.P. Arala-Chaves, and G.B. Wilson, Dialyzable transfer factor: An analytical review, F. Allerg. Immun. Clin. 23: 1 (1976).
H.H. Fudenberg, G.B. Wilson, and C.L. Smith, Immunotherapy with dialyzable leukocyte extracts and studies of their antigen-specific (transfer factor) activity, Proc. Virchow-Pirquet Med. Soc. 34: 3 (1980).
H.H. Fudenberg and G.B. Wilson, Dialyzable transfer factor: Clinical uses and studies on purification of the activity, in: “Current Topics in Clinical Chemistry Vol. 3, Clinical Immunochemistry, Chemical and Cellular Basis and Application in Disease,” S. Natelson, A.J. Pesce, A.A. Dietz, eds., American Association for Clinical Chemistry, Washington (1978).
H.H. Fudenberg, G.B. Wilson, J.M. Goust, K. Nekam, and C.L. Smith: A review of clinical results and immunological methods for donor selection, evaluation of activities, and patient monitoring, in: “Thymus, Thymic Hormones and T Lymphocytes,” F. Aiuti and H. Wigzell, eds., Academic Press, London (1980).
G.B. Wilson and H.H. Fudenberg, Is the Controversy about “Transfer Factor” Nearing an End?, Immunol. Today, In press, 1983.
G.B. Wilson, J.F. Metcalf Jr., and H.H. Fudenberg, Treatment of Mycobacterium fortuitum pulmonary infection with “Transfer Factor” (TF): New methodology for evaluating TF potency and predicting clinical response, Clin. Immunol. Immunopathol. 23: 478 (1982).
H.H. Fudenberg, G.B. Wilson, R.H. Keller, J.F. Metcalf, E.E. Paulling, E.J. Stuart, and E. Floyd, Clinical applications of the leukocyte migration inhibition assay - New methods for determining transfer factor potency and for predicting clinical response, in: “Fourth International Transfer Factor Workshop,” C.H. Kirkpatrick, H.S. Lawrence, and D.R. Burger, eds., Academic Press, New York (1983).
G.B. Wilson and H.H. Fudenberg, Leukocyte migration inhibition as a method for assaying transfer factor activities, Lymphokines 4: 107 (1981).
G.B. Wilson, H.H. Fudenberg, and M. Horsmanheimo, Effects of dialyzable leukocyte extracts (DLE) with transfer factor (TFd) activity on leukocyte migration in vitro. I. Antigen-dependent inhibition and antigen-independent inhibition and enhancement of migration, J. Lab. Clin. Med. 93: 800 (1979).
G.B.Wison, G.V. Paddock, and H.H. Fudenberg, Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides, Thymus 2: 257 (1981).
K.Y. Tsang, J.F. Pan, G.B. Wilson, and H.H. Fudenberg, Osteosarcoma-specific dialyzable leukocyte extracts: Prophylaxis post-surgery in an animal model of human osteosarcoma, J. Clin. Invest., manuscript in preparation.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Fudenberg, H.H., Wilson, G.B., Tsang, K.Y. (1984). Evaluation of “Transfer Factor” Potency and Prediction of Clinical Response. In: Fudenberg, H.H., Whitten, H.D., Ambrogi, F. (eds) Immunomodulation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9358-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9358-4_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9360-7
Online ISBN: 978-1-4615-9358-4
eBook Packages: Springer Book Archive